Postoperative neuroleptic malignant syndrome that occurred repeatedly in a patient with cerebral palsy

Paediatric Anaesthesia

Volumn 17, Issue 3, 2007, Pages 281-284

  Tsuchiya, Naohisa ^a   Morimura, Eri ^a   Hanafusa, Tetsuji ^a   Shinomura, Tetsutaro ^a  

^a OTSU RED CROSS HOSPITAL   (Japan)

Author keywords

Anesthetics; Cerebral palsy; Neuroleptic malignant syndrome; Nondepolarizing muscle relaxants

Indexed keywords

ANESTHETIC AGENT; CARBAMAZEPINE; DANTROLENE; FENTANYL; INHALATION ANESTHETIC AGENT; ISOFLURANE; LIDOCAINE; MIDAZOLAM; MUSCLE RELAXANT AGENT; NITROUS OXIDE; PHENOBARBITAL; THIOPENTAL; VALPROIC ACID; VECURONIUM;

ANESTHESIA COMPLICATION; ARTICLE; ASPIRATION PNEUMONIA; BLOOD PRESSURE; CASE REPORT; CEREBRAL PALSY; CONSCIOUSNESS; CONVALESCENCE; DIAPHORESIS; DRUG FEVER; DRUG INDUCED DISEASE; GASTROESOPHAGEAL REFLUX; GENERAL ANESTHESIA; HUMAN; ILEUS; LEUKOCYTOSIS; MALE; NEUROLEPTIC MALIGNANT SYNDROME; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; RIGIDITY; SCHOOL CHILD; SEIZURE; SIDE EFFECT; TACHYCARDIA; TACHYPNEA; UNSPECIFIED SIDE EFFECT;

ANESTHESIA, GENERAL; ANTIPSYCHOTIC AGENTS; BODY TEMPERATURE; CEREBRAL PALSY; CHILD; CREATINE KINASE; DANTROLENE; HUMANS; LEUKOCYTE COUNT; MALE; MUSCLE RELAXANTS, CENTRAL; NEUROLEPTIC MALIGNANT SYNDROME; POSTOPERATIVE PERIOD; RECURRENCE; RISK FACTORS;

EID: 33846616278     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2006.02079.x     Document Type: Article

References (13)

1. Adnet P, Lestavel P, Krivosic-Horber R. Neuroleptic malignant syndrome. Br J Anaesth 2000; 85: 129-135.
2. Portel L, Hilbert G, Gruson D et al. Malignant hyperthermia and neuroleptic malignant syndrome in a patient during treatment for acute asthma. Acta Anaesthesiol Scand 1999; 43: 107-110.
3. Vitkun SA, Boccio RV, Poppers PJ. Anesthetic management of a patient with neuroleptic malignant syndrome. J Clin Anesth 1990; 2: 188-191.
4. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985; 142: 1137-1145.
5. Viejo LF, Morales V, Punal P et al. Risk factors in neuroleptic malignant syndrome. A case-control study. Acta Psychiatr Scand 2003; 107: 45-49.
6. Gurrera RJ. Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia? Clin Neuropharmacol 2002; 25: 183-193.
7. Nisijima K, Kusakabe Y, Ohtuka K et al. Addition of carbamazepine to long-term treatment with neuroleptics may induce neuroleptic malignant syndrome. Biol Psychiatry 1998; 44: 930-931.
8. Patel P, Bristow G. Postoperative neuroleptic malignant syndrome. A case report. Can J Anaesth 1987; 34: 515-518.
9. Cardone C, Szenohradszky J, Yost S et al. Activation of brain acetylcholine receptors by neuromuscular blocking drugs. A possible mechanism of neurotoxicity. Anesthesiology 1994; 80: 1155-1161.
10. Yaffe K, Ferriero D, Barkovich AJ et al. Reversible MRI abnormalities following seizures. Neurology 1995; 45: 104-108.
11. Devanand DP, Dwork AJ, Hutchinson ER et al. Does ECT alter brain structure? Am J Psychiatry 1994; 151: 957-970.
12. Addonizio G, Susman V. Neuroleptic malignant syndrome and use of anesthetic agents. Am J Psychiatry 1986; 143: 127-128.
13. Geiduschek J, Cohen SA, Khan A et al. Repeated anesthesia for a patient with neuroleptic malignant syndrome. Anesthesiology 1988; 68: 134-137.